|
MARVELD2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.54159999987691E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.60540000004872E-06 |
| Normal-vs-Stage2 |
2.027600E-04 |
| Normal-vs-Stage3 |
1.411240E-04 |
| Normal-vs-Stage4 |
4.31889999985557E-07 |
| Stage1-vs-Stage2 |
2.602200E-01 |
| Stage1-vs-Stage3 |
1.264040E-01 |
| Stage1-vs-Stage4 |
4.043800E-03 |
| Stage2-vs-Stage3 |
8.321200E-01 |
| Stage2-vs-Stage4 |
2.861200E-01 |
| Stage3-vs-Stage4 |
3.917200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.34490000003318E-06 |
| Normal-vs-AfricanAmerican |
1.88925999999867E-05 |
| Normal-vs-Asian |
1.241550E-02 |
| Caucasian-vs-AfricanAmerican |
1.787600E-01 |
| Caucasian-vs-Asian |
4.193800E-01 |
| AfricanAmerican-vs-Asian |
5.750800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.12280000431309E-08 |
| Normal-vs-Female |
1.353020E-04 |
| Male-vs-Female |
6.826800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.40460000000553E-06 |
| Normal-vs-Extreme_Weight |
4.33239999997337E-06 |
| Normal-vs-Obese |
8.37810000000605E-05 |
| Normal-vs-Extreme_Obese |
1.945750E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.370200E-01 |
| Normal_Weight-vs-Obese |
1.788840E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.064800E-01 |
| Extreme_Weight-vs-Obese |
7.643000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.507600E-01 |
| Obese-vs-Extreme_Obese |
9.772800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.83660000000674E-05 |
| Normal-vs-Age(41-60Yrs) |
4.025500E-04 |
| Normal-vs-Age(61-80Yrs) |
2.1599999999955E-05 |
| Normal-vs-Age(81-100Yrs) |
3.597600E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.225700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.618000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.955600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.940300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.581900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.079200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.16930000000093E-05 |
| Normal-VS-Type2 PRCC |
2.96049999959358E-07 |
| Normal-VS-KIRP CIMP |
1.27049999998352E-06 |
| Normal-VS-Unclassified PRCC |
8.164800E-03 |
| Type1 PRCC-VS-Type2 PRCC |
2.27889999999675E-05 |
| Type1 PRCC-VS-KIRP CIMP |
1.955890E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
9.724400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.521000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.000100E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.014500E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.68009999935404E-08 |
| Normal-vs-N1 |
4.82839999982332E-07 |
| Normal-vs-N2 |
3.233800E-02 |
| N0-vs-N1 |
6.209400E-01 |
| N0-vs-N2 |
9.045600E-01 |
| N1-vs-N2 |
8.977200E-01 |
|
|
